Stocks Health care VANI
NASDAQ · Health careVivani Medical, Inc. (VANI)
It posted a net loss of $26.3M. In fiscal 2025 capital spending exceeded operating cash flow by $25.5M. At June 30, 2026 it held $19.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Key facts about Vivani Medical, Inc.
- Net worth
- Vivani Medical, Inc. has a market value (market cap) of $101.5M at the latest share price, and shareholders' equity of $19M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $0, with a net loss of $26.6M.
- Cash flow
- In fiscal 2025 operations used $24.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Vivani Medical, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Vivani Medical, Inc. does
Vivani Medical, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker VANI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$26.6M | -$0.43 | -$25.5M |
| 2024 | $0 | -$23.5M | -$0.43 | -$21.3M |
| 2023 | n/a | -$25.7M | -$0.50 | -$24.6M |
| 2022 | n/a | -$13.9M | n/a | -$19.1M |
| 2021 | n/a | -$12.8M | -$0.27 | -$11.5M |
| 2020 | n/a | -$14.9M | -$0.72 | -$17.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Vivani Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 30, 2026
- October 29, 2026
- September 16, 2026
- August 17, 2026
- August 13, 2026
- August 13, 2026
- August 6, 2026
- July 16, 2026
- July 7, 2026
- June 30, 2026
Insider trades
What the people running Vivani Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 15, 2026 | Mendelsohn AaronDirector | Gave as a gift | 20,000 | - |
| July 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 793,650 | $1M |
| June 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 1,587,301 | $2M |
| May 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 1,587,301 | $2M |
| April 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 1,587,301 | $2M |
| March 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 1,310,680 | $1.4M |
| March 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 264,551 | $333.3K |
| February 15, 2026 | Williams GreggDirector, 10% owner | Boughtindirect | 1,601,941 | $1.6M |
Who owns VANI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Williams Gregg13D, may seek influence with 4 related filers | 47.1% | May 19, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 38 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Vanguard Capital Management LLC | 1,768,077 | +237,144 |
| Tanager Wealth Management LLP | 607,276 | -33,809 |
| Geode Capital Management, LLC | 587,745 | -12,833 |
| Tudor Investment Corp ET AL | 410,902 | -15,400 |
| Commonwealth Equity Services, LLC | 330,565 | 0 |
| Vanguard Fiduciary Trust Co | 325,462 | +61,631 |
| BlackRock, Inc. | 301,828 | +4,330 |
| Monetary Management Group Inc | 193,977 | 0 |
| State Street Corp | 154,965 | 0 |
| Northern Trust Corp | 116,907 | +20,446 |
| MAI Capital Management | 99,870 | new |
| UBS Group AG | 51,108 | -286,641 |
| Armstrong Advisory Group, Inc | 45,000 | -20,000 |
| XTX Topco Ltd | 31,298 | +20,604 |
| Susquehanna International Group, Llp | 28,346 | -57,940 |
| Vanguard Global Advisers, LLC | 16,279 | 0 |
| StoneX Group Inc. | 14,143 | new |
| Kestra Private Wealth Services, LLC | 12,216 | 0 |
| Headlands Technologies LLC | 11,271 | new |
| Marshall Wace, Llp | 11,161 | -81,108 |
Insiders
2 insiders reported holding 37,080,906 shares in total, about $41.7M at the last price.
| Holder | Shares |
|---|---|
| Williams GreggDirector, 10% owner | 36,912,73636,912,736 held indirectly |
| Mendelsohn AaronDirector | 168,170 |
Questions about VANI
What does Vivani Medical, Inc. do?
Vivani Medical, Inc. is a company in the Health care sector, listed on NASDAQ as VANI. Its shares trade on NASDAQ under the ticker VANI.
What is Vivani Medical, Inc.'s net worth?
Vivani Medical, Inc. has a market value (market cap) of $101.5M at the latest share price, and shareholders' equity of $19M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Vivani Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $26.3M.
When did Vivani Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from October 30, 2026.
When is Vivani Medical, Inc.'s next earnings report?
Vivani Medical, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare VANI with
Follow VANI
Get an email when Vivani Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Vivani Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.